Cannabinoid Receptor Type 2 Agonist, GW405833, Reduced the Impacts of MDA-MB-231 Breast Cancer Cells on Bone Cells.

大麻素受体 2 型激动剂 GW405833 降低了 MDA-MB-231 乳腺癌细胞对骨细胞的影响